Overcoming NK cell resistance in triple-negative breast cancer via adcc with a humanized anti-CD147 antibody
Abstract Triple-negative breast cancer (TNBC) is an aggressive and clinically challenging subtype defined by the absence of estrogen receptor, progesterone receptor, and HER2 amplification, resulting in poor prognosis and limited therapeutic options. Targeting alternative molecular pathways is urgen...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Springer
2025-10-01
|
| Rangatū: | Cancer Immunology, Immunotherapy |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1007/s00262-025-04203-z |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|